Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05627323
Title A Phase 1 Study to Evaluate CHM-1101 CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Chimeric Therapeutics
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST